ANCC Ambulatory Care Nursing Certification Exam

Access More Questions

In addition to its glucose-lowering effects, which of the following is a well-established benefit of initiating an SGLT2 inhibitor, such as empagliflozin, in a patient with type 2 diabetes and established cardiovascular disease?

Significant weight gain. Increased risk of hypoglycemia when used as monotherapy. Reduction in the risk of hospitalizations for heart failure. Improvement in diabetic gastroparesis symptoms.

Correct Answer:

Reduction in the risk of hospitalizations for heart failure.

Access more questions from this quiz

Continue to ANCC Ambulatory Care Nursing Certification Exam for more practice questions and the full quiz experience.

Access More Questions